THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)
Clinical trial NCT02561234 updates: 1. start date: 2015-10-01 → 2015-10-22 2. completion date: 2019-05-01 → 2019-05-28 3. primary completion date: 2019-05-01 → 2019-05-28 4. enrollment: 98 → 76 participants 5. allocation: RANDOMIZED → NON_RANDOMIZED 6. collaborators added: Aeglea Biotherapeutics (Study sponsor)
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical